A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The purpose of this study is to describe the clinical and health-related outcomes of amivantamab-containing regimens for the treatment of common epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSCLC; most common type of lung cancer) in a real-world setting. Metastatic NSCLC is when this disease spreads to other parts of body. NSCLC may occur due to mutations (changes) in many genes including epidermal growth factor receptor (EGFR).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent ma potwierdzonego raka płuca (NSCLC) z konkretnymi zmianami w genie EGFR (delecje w eksonie 19 lub substytucja L858R w eksonie 21) i lekarz uznał, że kwalifikuje się do leczenia amivantamabem.
- •Pacjent (lub jego prawny opiekun) musi podpisać zgodę na udział w badaniu i możliwość sprawdzenia danych medycznych.
- •Pacjent po raz pierwszy rozpocznie leczenie amivantamabem w ciągu 4 tygodni od wizyty rozpoczynającej zbieranie danych.
- •Decyzja o leczeniu amivantamabem została podjęta przed włączeniem pacjenta do badania i jest niezależna od decyzji o jego udziale w badaniu.
✗ Disqualifies
- •Pacjent nie może otrzymywać innego aktywnego leczenia przeciwrakowego zaawansowanego NSCLC, które nie jest zatwierdzone do stosowania razem z amivantamabem.
- •Pacjent nie może być leczony amivantamabem w ramach innego badania klinicznego lub w ramach programu „dobrej woli”.
- •Pacjenci, którzy nie otrzymują amivantamabu, ale są leczeni podobnym lekiem biologicznym niebędącym oryginałem.
- •Pacjenci z przeciwwskazaniami do amivantamabu lub innych leków niezbędnych do stosowanego leczenia amivantamabem.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 6, 2026
- Sex
- No restrictions
Locations (75)
University Hospital Graz
Graz, Austria
Klinikum Klagenfurt am Worthersee
Klagenfurt, Austria
UZ Brussel
Brussels, Belgium
UZ Antwerpen
Edegem, Belgium
Jessa Ziekenhuis
Hasselt, Belgium
Az Groeninge
Kortrijk, Belgium
Chu Helora Hospital La Louviere Site Jolimont
La Louvière, Belgium
CHU de Liege
Liège, Belgium
Vitaz
Sint-Niklaas, Belgium
Fakultni nemocnice Brno
Brno, Czechia
Fakultni nemocnice Hradec Kralove
Hradec Králové, Czechia
Fakultni nemocnice Olomouc
Olomouc, Czechia
Fakultni Thomayerova nemocnice
Prague, Czechia
MVZ am Klinikum Aschaffenburg Onkologie
Aschaffenburg, Germany
Evangelisches Klinikum Bethel
Bielefeld, Germany
Augusta Kliniken Bochum Hattingen
Bochum, Germany
Klinikum Chemnitz gGmbH
Chemnitz, Germany
Haematologie u Onkologie Koeln MV Zentrum
Cologne, Germany
Kliniken der Stadt Köln gGmbH, Krankenhaus Köln-Mehrheim
Cologne, Germany
Kliniken Essen-Mitte; Evangelische Huyssens-Stiftung
Essen, Germany
Universitaetsklinikum Essen
Essen, Germany
Facharztzentrum Eppendorf
Hamburg, Germany
Onkologie am Raschplatz
Hanover, Germany
Klinikum Region Hannover Klinikum Siloah
Hanover, Germany
Lungenklinik Hemer
Hemer, Germany
Klinikum Konstanz
Konstanz, Germany
MVZ fur Hamatologie und Onkologie Rhein Kreis GmbH
Neuss, Germany
Knappschaft Kliniken MVZ Nord GmbH
Recklinghausen, Germany
MVZ Onkologie Groschek Keller
Stolberg, Germany
Bundeswehrkrankenhaus Ulm
Ulm, Germany
Rabin Medical Center
Petah Tikva, Israel
Sheba Medical Center
Ramat Gan, Israel
Assuta MC
Tel Aviv, Israel
Ospedale San Giuseppe Moscati di Avellino
Avellino, Italy
Oncologia Medica - Irccs - Istituto Tumori Giovanni Paolo II
Bari, Italy
ASST Spedali Civili Brescia
Brescia, Italy
Istituto di Candiolo, IRCCS
Candiolo, Italy
PO G.Rodolico, AOU Policlinico-Vittorio Emanuele Catania
Catania, Italy
Azienda Ospedaliera Pugliese Ciaccio Catanzaro
Catanzaro, Italy
Ospedale Policlinico San Martino IRCCS
Genova, Italy
Azienda Ospedaliera ''Vito Fazzi''
Lecce, Italy
San Raffaele Hospital
Milan, Italy
Istituto Dei Tumori Di Milano
Milan, Italy
European Institute of Oncology
Milan, Italy
ASST Grande Ospedale Metropolitano Niguarda
Milan, Italy
San Gerardo Hospital
Monza, Italy
Fondazione G Pascale Istituto Nazionale Tumori IRCCS
Naples, Italy
Azienda Ospedaliero Universitaria Maggiore della Carita di Novara
Novara, Italy
ASL Gallura - Ospedale Giovanni Paolo II
Olbia, Italy
Aou San Luigi Gonzaga
Orbassano, Italy
Azienda Ospedaliero Universitaria Policlinico Paolo Giaccone
Palermo, Italy
A.O.R Villa Sofia Cervello
Palermo, Italy
Azienda Ospedaliero-Universitaria Di Parma
Parma, Italy
Fondazione Policlinico Universitario A Gemelli IRCCS
Roma, Italy
Campus Bio Medico di Roma
Roma, Italy
Istituto Nazionale Tumori Regina Elena
Rome, Italy
Azienda Ospedaliero Universitaria di Sassari
Sassari, Italy
Ospedali Riuniti Di Ancona
Torrette-Ancona, Italy
Azienda Sanitaria Territoriale Pesaro Urbino
Urbino, Italy
Hosp Reina Sofia
Córdoba, Spain
Hosp. de Jerez de La Frontera
Jerez de la Frontera, Spain
Hosp. Univ. Lucus Augusti
Lugo, Spain
Complexo Hosp. Univ. de Ourense
Ourense, Spain
Hosp. Univ. Son Espases
Palma de Mallorca, Spain
Hosp. Clinico Univ. de Santiago
Santiago de Compostela, Spain
Hospital Universitario Virgen Rocio
Seville, Spain
Hosp. Clinico Univ. de Valladolid
Valladolid, Spain
Royal United Hospital
Bath, United Kingdom
Velindre Hospital
Cardiff, United Kingdom
Eastbourne District General Hospital
Eastbourne, United Kingdom
Royal Surrey County Hospital NHS Trust
Guildford, United Kingdom
New Cross Hospital
Heath Town, United Kingdom
Royal Marsden Hospital
London, United Kingdom
The Christie NHS Foundation Trust Christie Hospital
Manchester, United Kingdom
Royal Marsden Hospital (Sutton)
Sutton, United Kingdom
Trial contact
Study Contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/7/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.